Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sun B Sowers

Showing results (1-10 of 17) with videos related to

Pageof 2
Sort By:
Msphere|September 14, 2018
Development and Use of an Endpoint Titration Assay To Characterize Mumps IgG Avidity following Measles, Mumps, and Rubella Vaccination and Wild-Type Mumps InfectionSara Mercader, Marcia McGrew, Sun B Sowers, et al.
Clinical and Vaccine Immunology : CVI|December 28, 2013
Estimates of mumps seroprevalence may be influenced by antibody specificity and serologic methodDonald R Latner, Marcia McGrew, Nobia J Williams, et al.
Research Square|November 19, 2025
A Computationally Optimised Structural Integrity Sequence Enhances Vaccine Stability, Yield and Safety ProfileArthur Sarron, Sun B Sowers, Yaroslav Tsybovsky, et al.
Journal of Clinical Microbiology|November 21, 2022
Performance Characteristics of Six Immunoglobulin M Enzyme-Linked Immunosorbent Assays Used for Laboratory Confirmation of MeaslesSun B Sowers, Kiana Anthony, Sara Mercader, et al.
Pediatrics International : Official Journal of the Japan Pediatric Society|December 3, 2022
Etiological analysis of discarded measles in the context of a measles outbreak among a highly immunized populationNuria Torner, Sara Mercader, Angela Dominguez, et al.
The Journal of Infectious Diseases|December 8, 2025
Durability of the Mumps Antibody Response After the Third Dose of MMR VaccineSun B Sowers, Huong Q Nguyen, Nina B Masters, et al.
Open Forum Infectious Diseases|April 23, 2025
Patterns of Decline in Measles, Mumps, and Rubella Neutralizing Antibodies and Protection Levels Through 10 Years After a Second and Third Dose of MMR VaccineChelsea S Lutz, Huong Q Nguyen, David L McClure, et al.
Open Forum Infectious Diseases|July 8, 2024
Identifying a Level of Neutralizing Antibody That Correlates With Protection From Clinical Mumps Disease During a 2017 Mumps Outbreak Among Military Service MembersSun B Sowers, Nakia S Clemmons, Sara Mercader, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 13, 2024
The Effects of Vaccination Status and Age on Clinical Characteristics and Severity of Measles Cases in the United States in the Postelimination Era, 2001-2022Jessica Leung, Naeemah A Munir, Adria D Mathis, et al.
Clinical and Vaccine Immunology : CVI|June 24, 2016
High Concentrations of Measles Neutralizing Antibodies and High-Avidity Measles IgG Accurately Identify Measles Reinfection CasesSun B Sowers, Jennifer S Rota, Carole J Hickman, et al.
Pageof 2

Showing results (1-10 of 17) with videos related to

Sort By:
Pageof 2
Msphere|September 14, 2018
Development and Use of an Endpoint Titration Assay To Characterize Mumps IgG Avidity following Measles, Mumps, and Rubella Vaccination and Wild-Type Mumps InfectionSara Mercader, Marcia McGrew, Sun B Sowers, et al.
Clinical and Vaccine Immunology : CVI|December 28, 2013
Estimates of mumps seroprevalence may be influenced by antibody specificity and serologic methodDonald R Latner, Marcia McGrew, Nobia J Williams, et al.
Research Square|November 19, 2025
A Computationally Optimised Structural Integrity Sequence Enhances Vaccine Stability, Yield and Safety ProfileArthur Sarron, Sun B Sowers, Yaroslav Tsybovsky, et al.
Journal of Clinical Microbiology|November 21, 2022
Performance Characteristics of Six Immunoglobulin M Enzyme-Linked Immunosorbent Assays Used for Laboratory Confirmation of MeaslesSun B Sowers, Kiana Anthony, Sara Mercader, et al.
Pediatrics International : Official Journal of the Japan Pediatric Society|December 3, 2022
Etiological analysis of discarded measles in the context of a measles outbreak among a highly immunized populationNuria Torner, Sara Mercader, Angela Dominguez, et al.
The Journal of Infectious Diseases|December 8, 2025
Durability of the Mumps Antibody Response After the Third Dose of MMR VaccineSun B Sowers, Huong Q Nguyen, Nina B Masters, et al.
Open Forum Infectious Diseases|April 23, 2025
Patterns of Decline in Measles, Mumps, and Rubella Neutralizing Antibodies and Protection Levels Through 10 Years After a Second and Third Dose of MMR VaccineChelsea S Lutz, Huong Q Nguyen, David L McClure, et al.
Open Forum Infectious Diseases|July 8, 2024
Identifying a Level of Neutralizing Antibody That Correlates With Protection From Clinical Mumps Disease During a 2017 Mumps Outbreak Among Military Service MembersSun B Sowers, Nakia S Clemmons, Sara Mercader, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 13, 2024
The Effects of Vaccination Status and Age on Clinical Characteristics and Severity of Measles Cases in the United States in the Postelimination Era, 2001-2022Jessica Leung, Naeemah A Munir, Adria D Mathis, et al.
Clinical and Vaccine Immunology : CVI|June 24, 2016
High Concentrations of Measles Neutralizing Antibodies and High-Avidity Measles IgG Accurately Identify Measles Reinfection CasesSun B Sowers, Jennifer S Rota, Carole J Hickman, et al.
Pageof 2